RWE breaks ground on second solar farm in Ohio, creating jobs and economic opportunities in Licking County
Onsite construction underway at RWE's 98 MWac Union Ridge Solar farm in Licking County, Ohio
RWE and MasTec Renewables partnering with local labor unions to tap into Ohio's strong craft workforce for the project
Union Ridge to contribute more than $35 million to local schools, county programs and continue educational partnership with C-TEC to help build Ohio's future energy workforce
AUSTIN, Texas, May 13, 2025 /PRNewswire/ -- RWE, the third largest renewable energy company in America, is building its second solar farm in Ohio and further expanding its portfolio of energy assets in the Buckeye State. Onsite construction is underway at the 98-megawatt (MWac) Union Ridge Solar project in Licking County, Ohio, which RWE acquired from Leeward Renewable Energy (LRE) in the fall of 2024.
RWE's investment in Union Ridge during the project's construction phase will produce an estimated $68 million in new local economic activity for Licking County. This includes the direct employment of about 280 workers onsite at peak construction and associated wages and benefits, as well as increased purchases of local goods and services and local sales tax payments.
RWE and construction partner MasTec Renewables aim to leverage Ohio's strong craft union workforce for the construction phase of the project. The companies are collaborating with the Laborers' International Union of North America, International Union of Operating Engineers and International Brotherhood of Electrical Workers local halls in Licking County and across the state to hire skilled union laborers, operators and electricians to construct this utility-scale solar project.
Kevin Kroll, Chief Operating Officer, RWE Clean Energy: "Our Union Ridge project is an example of how we partner with leading American companies to bring job growth and critical economic activity to communities across America with our homegrown energy. Through our partnership with MasTec, we are helping to create new employment opportunities for Licking County residents and support Ohio's current and future skilled labor workforce."
Mike Flynn, Senior Vice President - Operations, MasTec Renewables: "Our partnership with RWE on the Union Ridge Solar project showcases MasTec's dedication to sparking local economic growth and strengthening workforce development. By harnessing Ohio's talented labor pool, we're doing more than constructing a solar farm; we're investing in the community's future. This collaboration will generate hundreds of jobs for Licking County residents, spanning roles from skilled laborers to utility electricians and solar panel assemblers. We're proud to work alongside RWE in driving the clean energy transition while simultaneously bolstering local economies and providing valuable career opportunities for Ohioans."
John Wieland, Chief Development Officer, LRE (Leeward Renewable Energy): "LRE is proud to have fostered partnerships with C-TEC and local IBEW groups to collaboratively develop and establish the skilled training course in Licking County, through developing curriculum materials, donating First Solar modules, and other sponsorship contributions. We look forward to this Union Ridge Solar program paving the way for future generations all across Ohio to find good-paying careers in renewable energy."
RWE currently owns and operates about 400 MW of wind and solar assets across Ohio. Union Ridge will bring RWE's total operating capacity in the state to nearly 500 MW — capable of generating enough electricity to power more than 118,000 average homes annually.
Investing in Ohio Communities
RWE's Union Ridge project underscores RWE's commitment to fostering economic growth in local communities across Ohio. Once in operation, the project will provide more than $35 million in tax revenue over its 40-year lifespan to support the Southwest Licking Local School District, Harrison Township and other jurisdictions in Licking County.
Notably, RWE is continuing LRE's previously established partnership with the Career and Technology Education Centers of Licking County (C-TEC) Postsecondary Education Center to help build Ohio's future energy workforce through support for a joint educational and career training program. The Solar Energy Training Course trains students in the assembly, mounting and maintenance of solar arrays used on utility-scale solar facilities in Ohio.
For more information, visit americas.rwe.com.
For further inquiries:Patricia KakridasSr. Manager, Media & Public RelationsCorporate CommunicationsRWE Clean EnergyM + 619-753-5206E patricia.kakridas@rwe.com
RWE in the U.S. Through its subsidiary RWE Clean Energy, RWE is the third largest renewable energy company in the United States, with a presence in most U.S. states from coast to coast. RWE's team of about 2,000 employees in the U.S. stands ready to help meet the nation's growing energy needs. With its homegrown and fastest-to-market product, RWE supports the goal of American Energy dominance and independence. To that end, RWE Clean Energy is committed to increasing its already strong asset base of over 10 gigawatts of operating wind, solar and battery projects, focusing on providing high-quality jobs. RWE invests in local and rural communities while strengthening domestic manufacturing supporting the renaissance of American industry. This is complemented by RWE's energy trading business. RWE is also a major offtaker of American liquified natural gas (LNG).
As an energy company with a successful history spanning more than 125 years, RWE has an extensive knowledge of the energy markets and an excellent expertise in all major power generation and storage technologies, from nuclear, coal and gas to hydro, batteries, wind and solar.
View original content to download multimedia:https://www.prnewswire.com/news-releases/rwe-breaks-ground-on-second-solar-farm-in-ohio-creating-jobs-and-economic-opportunities-in-licking-county-302453954.html
SOURCE RWE
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 minutes ago
- Yahoo
Micron to invest $200 billion in US memory facilities
Memory chip maker Micron (MU) announced on Thursday that it will invest an additional $30 billion in the US, as it looks to build out its manufacturing and research and development facilities in Idaho and New York. The move brings Micron's total US manufacturing and R&D investments up to roughly $200 billion which will create some 90,000 direct and indirect jobs, the company said. Micron is receiving about $6.5 billion in funding from the US CHIPS Act. The plans call for Micron to build a second memory manufacturing plant at its Boise, Idaho, facility and a massive chip fabrication complex in New York. The company is also updating and expanding its Virginia plant. Micron also said it expects the second Idaho plant to help it bring its advanced high-bandwidth memory (HBM) manufacturing to the US. HBM is a key component in AI data centers. 'Micron's investment in advanced memory manufacturing and HBM capabilities in the U.S., with support from the Trump Administration, is an important step forward for the AI ecosystem,' Nvidia (NVDA) CEO Jensen Huang said in a statement. 'Micron's leadership in high-performance memory is invaluable to enabling the next generation of AI breakthroughs that NVIDIA is driving. We're excited to collaborate with Micron as we push the boundaries of what's possible in AI and high-performance computing,' Huang added. All totaled, Micron says the investments will allow the company to produce 40% of its DRAM memory in the US. Its initial Idaho plant is expected to begin pumping out the hardware in 2027. Micron also says it is set to begin preparing the ground for its New York facilities later this year. 'This approximately $200 billion investment will reinforce America's technological leadership, create tens of thousands of American jobs across the semiconductor ecosystem and secure a domestic supply of semiconductors—critical to economic and national security,' Micron CEO Sanjay Mehrotra said in a statement. 'We are grateful for the support from President Trump, Secretary Lutnick and our federal, state, and local partners who have been instrumental in advancing domestic semiconductor manufacturing.' Micron isn't the only company bringing HBM production to the US, though. South Korea's SK Hynix is also building a new HBM plant in Indiana as part of a $3.8 billion construction project. The Trump administration, and the Biden administration before it, has made onshoring semiconductor manufacturing a key component of its domestic agenda, as it seeks to wean itself off of the country's dependence on foreign-made chips. Companies ranging from Intel (INTC) and TSMC (TSM) to Samsung and GlobalFounderies (GFS) and others have recently announced plans to build or upgrade their facility throughout the country, thanks in part to billions of dollars in funding through the CHIPS Act. Email Daniel Howley at dhowley@ Follow him on X/Twitter at @DanielHowley. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
11 minutes ago
- Yahoo
BioNTech to Acquire CureVac in Stock Deal Valued Around $1.25 Billion
BioNTech will acquire all shares of CureVac after the two sides reached an agreement in a deal valued around $1.25 billion. Each share of CureVac, a clinical-stage biotech company, will be exchanged for about $5.46 in BioNTech American depositary shares. Upon the deal's closing, CureVac shareholders are expected to own between 4% and 6% of the German developer of RNA vaccines and immunotherapies. ICE Raids Have Sent Latino Shoppers Into Hiding and Big Brands Are Hurting The Secret to Retaining the Best Employees: Ask Them These Four Questions Here's How Much Money the U.S. Is Earning From Tariffs, in Charts How Home Depot Became Ground Zero in Trump's Deportation Push Supply Chains Become New Battleground in the Global Trade War BioNTech Chief Executive Ugur Sahin said the plan is to bring complementary capabilities between the two companies together to develop transformative cancer treatments. CureVac's operating subsidiary will become a wholly owned subsidiary of BioNTech following the close of the transaction. As part of this plan, BioNTech will integrate CureVac's research and manufacturing site in Tübingen, Germany. The deal was unanimously approved by both companies' management and supervisory boards. It is expected to close in 2025. Shares of CureVac surged 29% to $5.25 in premarket trading. Write to Denny Jacob at Pulls Outlook as Sales Fall Bojangles Is Exploring a Sale While the Fried-Chicken Market Is Hot Why Bosses Should Give Feedback in the Morning The Audacious Reboot of America's Nuclear Energy Program Muted May Inflation Defies Tariff Fears Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
11 minutes ago
- Yahoo
Is Fidelity Select Portfolio Medical Technology and Devices (FSMEX) a Strong Mutual Fund Pick Right Now?
If you have been looking for Sector - Health funds, a place to start could be Fidelity Select Portfolio Medical Technology and Devices (FSMEX). FSMEX has a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based on various forecasting factors like size, cost, and past performance. Zacks categorizes FSMEX as Sector - Health, a segment packed with options. Sector - Health mutual funds offer investors a focus on the healthcare industry, one of the largest sectors in the American economy. These funds can include everything from pharmaceutical companies to medical device manufacturers and for-profit hospitals. Fidelity is responsible for FSMEX, and the company is based out of Boston, MA. Fidelity Select Portfolio Medical Technology and Devices made its debut in April of 1998, and since then, FSMEX has accumulated about $4.48 billion in assets, per the most up-to-date date available. The fund is currently managed by Edward Yoon who has been in charge of the fund since May of 2007. Investors naturally seek funds with strong performance. This fund has delivered a 5-year annualized total return of 5.12%, and it sits in the middle third among its category peers. If you're interested in shorter time frames, do not dismiss looking at the fund's 3 -year annualized total return of 3.37%, which places it in the bottom third during this time-frame. It is important to note that the product's returns may not reflect all its expenses. Any fees not reflected would lower the returns. Total returns do not reflect the fund's [%] sale charge. If sales charges were included, total returns would have been lower. When looking at a fund's performance, it is also important to note the standard deviation of the returns. The lower the standard deviation, the less volatility the fund experiences. Over the past three years, FSMEX's standard deviation comes in at 18.22%, compared to the category average of 15.64%. Over the past 5 years, the standard deviation of the fund is 19.24% compared to the category average of 16.64%. This makes the fund more volatile than its peers over the past half-decade. Investors should note that the fund has a 5-year beta of 0.92, which means it is hypothetically less volatile than the market at large. Alpha is an additional metric to take into consideration, since it represents a portfolio's performance on a risk-adjusted basis relative to a benchmark, which in this case, is the S&P 500. With a negative alpha of -7.95, managers in this portfolio find it difficult to pick securities that generate better-than-benchmark returns. Costs are increasingly important for mutual fund investing, and particularly as competition heats up in this market. And all things being equal, a lower cost product will outperform its otherwise identical counterpart, so taking a closer look at these metrics is key for investors. In terms of fees, FSMEX is a no load fund. It has an expense ratio of 0.63% compared to the category average of 1.11%. Looking at the fund from a cost perspective, FSMEX is actually cheaper than its peers. While the minimum initial investment for the product is $0, investors should also note that there is no minimum for each subsequent investment. Fees charged by investment advisors have not been taken into considiration. Returns would be less if those were included. Overall, Fidelity Select Portfolio Medical Technology and Devices ( FSMEX ) has a high Zacks Mutual Fund rank, and in conjunction with its comparatively similar performance, average downside risk, and lower fees, Fidelity Select Portfolio Medical Technology and Devices ( FSMEX ) looks like a great potential choice for investors right now. Your research on the Sector - Health segment doesn't have to stop here. You can check out all the great mutual fund tools we have to offer by going to to see the additional features we offer as well for additional information. For analysis of the rest of your portfolio, make sure to visit for our full suite of tools which will help you investigate all of your stocks and funds in one place. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Get Your Free (FSMEX): Fund Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
